Menu

Request a Free Mesothelioma Information Guide

  • Information on top doctors and cancer centers
  • The latest clinical trials and treatment methods
  • Financial information to help with treatment costs
Request a Free Guide

Participating in a clinical trial allows those who have been diagnosed with a serious illness, like mesothelioma, to contribute to medical research. Each clinical trial has unique criteria and guidelines that prospective participants must meet in order to be considered for inclusion in the study. Because there are both benefits and risks to participating in a clinical trial it is always best to discuss any interest you may have with your doctor. Provided below is a list of active mesothelioma clinical trials that are still recruiting and enrolling participants. Click on a link to learn more about each study and the criteria for participation.

BEAT-meso: Bevacizumab and Atezolizumab in Malignant Pleural Mesothelioma


Conditions: Mesothelioma

Last Updated: July 13, 2020

Status: Recruiting

Pembrolizumab in Patients With Advanced Malignant Pleural Mesothelioma


Conditions: Mesothelioma

Last Updated: July 13, 2020

Status: Recruiting

Olaparib in People With Malignant Mesothelioma


Conditions: Mesothelioma

Last Updated: July 11, 2020

Status: Recruiting

Dose Individualization of Pemetrexed - IMPROVE-I


Conditions: Lung Neoplasms, Carcinoma, Non-Small-Cell Lung, Mesothelioma

Last Updated: July 10, 2020

Status: Recruiting

Dose Individualization of Pemetrexed - IMPROVE-III


Conditions: Lung Neoplasms, Carcinoma, Non-Small-Cell Lung, Mesothelioma

Last Updated: July 10, 2020

Status: Recruiting

Nivolumab and Ipilimumab in Treating Patients With Rare Tumors


Conditions: Carcinoma, Carcinoma, Squamous Cell, Adenocarcinoma, Neoplasms, Germ Cell and Embryonal, Mesothelioma, Nasopharyngeal Carcinoma, Breast Neoplasms, Cholangiocarcinoma, Carcinoma, Basal Cell, Gastrointestinal Stromal Tumors, Carcinoid Tumor, Carcinoma, Transitional Cell, Carcinoma, Adenoid Cystic, Teratoma, Adenocarcinoma of Lung, Carcinoma, Neuroendocrine, Pheochromocytoma, Seminoma, Choriocarcinoma, Cystadenocarcinoma, Cystadenocarcinoma, Serous, Carcinoma, Endometrioid, Paraganglioma, Chordoma, Fibromatosis, Aggressive, Hemangiosarcoma, Trophoblastic Neoplasms, Adenocarcinoma, Mucinous, Gestational Trophoblastic Disease, Adenocarcinoma, Clear Cell, Nerve Sheath Neoplasms, Neurofibrosarcoma, Fibroma, Thyroid Neoplasms, Cystadenocarcinoma, Mucinous, Pseudomyxoma Peritonei, Vulvar Neoplasms, Sex Cord-Gonadal Stromal Tumors, Adrenocortical Carcinoma, Carcinoma, Islet Cell, Paget Disease, Extramammary, Adenocarcinoma, Papillary, Carcinoma, Acinar Cell, Adenocarcinoma, Bronchiolo-Alveolar, Mixed Tumor, Mullerian, Neoplasms, Unknown Primary, Carcinoma, Giant Cell, Neoplasms

Last Updated: July 9, 2020

Status: Recruiting

A Study of SGN-CD228A in Advanced Solid Tumors


Conditions: Adenocarcinoma, Mesothelioma

Last Updated: July 6, 2020

Status: Recruiting

Dose Escalation Study to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of QBS10072S


Conditions: Neoplasm Metastasis, Astrocytoma, Brain Neoplasms, Mesothelioma, Cholangiocarcinoma, Tongue Neoplasms, Esophageal Neoplasms, Thymoma, Urologic Neoplasms

Last Updated: July 2, 2020

Status: Recruiting

Evaluation of Cell Changes in Blood and Tissue in Cancers of the Lung, Esophagus and Lung Lining


Conditions: Esophageal Neoplasms, Mesothelioma, Neoplasms

Last Updated: June 30, 2020

Status: Recruiting

Nivolumab and Ipilimumab +/- UV1 Vaccination as Second Line Treatment in Patients With Malignant Mesothelioma


Conditions: Mesothelioma, Lung Neoplasms

Last Updated: June 29, 2020

Status: Recruiting

Atezolizumab and Bevacizumab in Treating Patients With Rare Solid Tumors


Conditions: Carcinoma, Merkel Cell, Carcinoma, Carcinoma, Squamous Cell, Mesothelioma, Neuroendocrine Tumors, Nasopharyngeal Carcinoma, Lung Neoplasms, Carcinoma, Neuroendocrine

Last Updated: June 18, 2020

Status: Recruiting

Bosutinib in Combination With Pemetrexed in Patients With Selected Metastatic Solid Tumors


Conditions: Uterine Cervical Neoplasms, Mesothelioma, Carcinoma, Non-Small-Cell Lung, Thymoma, Thymus Neoplasms

Last Updated: June 15, 2020

Status: Recruiting

Anti-Mesothelin Immunotoxin LMB-100 Followed by Pembrolizumab in Malignant Mesothelioma


Conditions: Mesothelioma

Last Updated: June 12, 2020

Status: Recruiting

HMPL-453 in Advanced Malignant Mesothelioma


Conditions: Mesothelioma, Lung Neoplasms

Last Updated: June 12, 2020

Status: Recruiting

Tissue Procurement and Natural History Study of Patients With Malignant Mesothelioma


Conditions: Mesothelioma, Pancreatic Neoplasms, Stomach Neoplasms, Thymoma, Biliary Tract Neoplasms, Neoplasms

Last Updated: June 12, 2020

Status: Recruiting

Magnetic Resonance Imaging for Detection of Peritoneal Mesothelioma


Conditions: Mesothelioma

Last Updated: June 11, 2020

Status: Recruiting

A Trial of Niraparib in BAP1 and Other DNA Damage Response (DDR) Deficient Neoplasms (UF-STO-ETI-001)


Conditions: Melanoma, Carcinoma, Renal Cell, Mesothelioma, Cholangiocarcinoma, Neoplasms

Last Updated: June 5, 2020

Status: Recruiting

Pharmacokinetic Study of PM01183 in Combination With Irinotecan in Patients With Selected Solid Tumors


Conditions: Carcinoma, Sarcoma, Glioblastoma, Mesothelioma, Neuroendocrine Tumors, Endometrial Neoplasms, Stomach Neoplasms, Neoplasms

Last Updated: June 5, 2020

Status: Recruiting

Transarterial Chemoperfusion: Cisplatin, Methotrexate, Gemcitabine for Unresectable Pleural Mesothelioma


Conditions: Mesothelioma

Last Updated: June 3, 2020

Status: Recruiting

A Study of Budigalimab (ABBV-181) in Participants With Advanced Solid Tumors


Conditions: Neoplasms

Last Updated: June 2, 2020

Status: Recruiting

Study of Recombinant Human Anti-PD-1 Monoclonal Antibody in Patients With Advanced Tumours


Conditions: Mesothelioma

Last Updated: June 1, 2020

Status: Recruiting

CAR T Cells in Mesothelin Expressing Cancers


Conditions: Adenocarcinoma, Mesothelioma, Fallopian Tube Neoplasms, Adenocarcinoma of Lung

Last Updated: May 29, 2020

Status: Recruiting

Heated Intra-peritoneal Chemotherapy With Doxorubicin and Cisplatin for the Treatment of Resectable, Refractory, or Recurrent Abdominal or Pelvic Tumors in Pediatric Patients, T.O.A.S.T. I.T. Study


Conditions: Carcinoma, Sarcoma, Mesothelioma, Rhabdomyosarcoma, Ovarian Neoplasms, Carcinoma, Ovarian Epithelial, Lung Neoplasms, Liposarcoma, Fallopian Tube Neoplasms, Stomach Neoplasms, Rectal Neoplasms, Desmoplastic Small Round Cell Tumor, Colonic Neoplasms, Abdominal Neoplasms, Pelvic Neoplasms, Neoplasms

Last Updated: May 28, 2020

Status: Recruiting

Study of ASTX295 in Patients With Solid Tumors With Wild-Type p53


Conditions: Neoplasms

Last Updated: May 27, 2020

Status: Recruiting

Nivolumab With Chemotherapy in Pleural Mesothelioma After Surgery


Conditions: Mesothelioma

Last Updated: May 25, 2020

Status: Recruiting

Phase 1/2 Trial of TC-210 T Cells in Patients With Advanced Mesothelin-Expressing Cancer


Conditions: Lung Neoplasms, Carcinoma, Non-Small-Cell Lung, Mesothelioma, Cholangiocarcinoma

Last Updated: May 21, 2020

Status: Recruiting

Oral TrkA Inhibitor VMD-928 for Treatment of Advanced Adult Solid Tumors or Lymphoma


Conditions: Lymphoma, Carcinoma, Prostatic Neoplasms, Melanoma, Carcinoma, Squamous Cell, Leukemia, Myeloid, Acute, Ovarian Neoplasms, Lymphoma, Non-Hodgkin, Carcinoma, Hepatocellular, Stomach Neoplasms, Uterine Cervical Neoplasms, Esophageal Neoplasms, Mesothelioma, Squamous Cell Carcinoma of Head and Neck, Carcinoma, Adenoid Cystic, Pancreatic Neoplasms, Thymoma, Lung Neoplasms

Last Updated: May 18, 2020

Status: Recruiting

Ex-Vivo Expanded Allogeneic NK Cells For The Treatment Of Pediatric Solid Tumors


Conditions: Melanoma, Mesothelioma, Lung Neoplasms, Skin Neoplasms, Bone Neoplasms, Genital Neoplasms, Female, Soft Tissue Neoplasms, Endocrine Gland Neoplasms, Pharyngeal Neoplasms, Mouth Neoplasms, Thyroid Neoplasms, Genital Neoplasms, Male, Urologic Neoplasms, Sarcoma, Thyroid Diseases, Recurrence, Neoplasms

Last Updated: May 13, 2020

Status: Recruiting

A Study of XmAb®20717 in Subjects With Selected Advanced Solid Tumors


Conditions: Carcinoma, Melanoma, Carcinoma, Squamous Cell, Uterine Cervical Neoplasms, Mesothelioma, Nasopharyngeal Carcinoma, Breast Neoplasms, Cholangiocarcinoma, Lung Neoplasms, Carcinoma, Basal Cell, Squamous Cell Carcinoma of Head and Neck, Endometrial Neoplasms, Carcinoma, Non-Small-Cell Lung, Colorectal Neoplasms, Carcinoma, Neuroendocrine, Thymoma, Small Cell Lung Carcinoma, Anus Neoplasms, Vulvar Neoplasms

Last Updated: May 12, 2020

Status: Recruiting

Malignant Pleural Disease Treated With Autologous T Cells Genetically Engineered to Target the Cancer-Cell Surface Antigen Mesothelin


Conditions: Mesothelioma, Pleural Diseases

Last Updated: May 11, 2020

Status: Recruiting

Phase 1 Study of CK-301 (Cosibelimab) as a Single Agent in Subjects With Advanced Cancers


Conditions: Carcinoma, Merkel Cell, Lymphoma, Carcinoma, Endometrial Neoplasms, Mesothelioma, Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, Carcinoma, Small Cell

Last Updated: May 11, 2020

Status: Recruiting

Tissue Procurement for Gastric Cancer, Gastrointestinal Stromal Tumors (GIST), Esophageal Cancer, Pancreas Cancer, Hepatocellular Cancer, Biliary Cancer, Neuroendocrine, Peritoneal Mesothelioma, Anal Cancer and Colorectal Cancer in Patients Undergoing Surgery or Biopsy


Conditions: Stomach Neoplasms, Esophageal Neoplasms, Mesothelioma, Gastrointestinal Stromal Tumors, Anus Neoplasms, Pancreatic Neoplasms, Liver Neoplasms, Carcinoma, Hepatocellular, Gastrointestinal Neoplasms

Last Updated: May 7, 2020

Status: Recruiting

177Lu-DOTA-TATE and Olaparib in Somatostatin Receptor Positive Tumours


Conditions: Mesothelioma, Neuroendocrine Tumors, Thymoma

Last Updated: May 3, 2020

Status: Recruiting

Rapid Autopsy and Procurement of Cancer Tissue


Conditions: Mesothelioma, Urogenital Neoplasms

Last Updated: April 24, 2020

Status: Recruiting

Accelerated Hypofractionated Radiotherapy in the Treatment of Malignant Pleural Mesothelioma


Conditions: Mesothelioma

Last Updated: April 20, 2020

Status: Recruiting

Pembrolizumab Plus Autologous Dendritic Cell Vaccine in Patients With PD-L1 Negative Advanced Mesothelioma Who Have Failed Prior Therapies


Conditions: Mesothelioma, Disease Progression

Last Updated: April 20, 2020

Status: Recruiting

Continuous 24h Intravenous Infusion of Mithramycin, an Inhibitor of Cancer Stem Cell Signaling, in People With Primary Thoracic Malignancies or Carcinomas, Sarcomas or Germ Cell Neoplasms With Pleuropulmonary Metastases


Conditions: Sarcoma, Mesothelioma, Lung Neoplasms, Esophageal Neoplasms, Neoplasms, Germ Cell and Embryonal, Thymus Neoplasms, Neoplasms

Last Updated: April 17, 2020

Status: Recruiting

A Study to Assess a PI3Kδ Inhibitor (IOA-244) in Patients With Metastatic Cancers


Conditions: Neoplasm Metastasis

Last Updated: April 1, 2020

Status: Recruiting

A Study of Nivolumab and Chemotherapy Followed by Surgery for Mesothelioma


Conditions: Mesothelioma

Last Updated: March 25, 2020

Status: Recruiting

First-in-human Study of S-588210 (S-488210+S-488211)


Conditions: Mesothelioma

Last Updated: March 19, 2020

Status: Recruiting

Phase 1 Study of INBRX-109 in Subjects With Locally Advanced or Metastatic Solid Tumors Including Sarcomas


Conditions: Adenocarcinoma, Sarcoma, Mesothelioma

Last Updated: March 11, 2020

Status: Recruiting

Adoptive Transfer of Tumor Infiltrating Lymphocytes for Advanced Solid Cancers


Conditions: Carcinoma, Merkel Cell, Mesothelioma, Neuroendocrine Tumors, Neoplasms, Squamous Cell, Carcinoma, Squamous Cell, Microsatellite Instability

Last Updated: March 10, 2020

Status: Recruiting

A Pilot Study to Explore the Role of Gut Flora in Metastatic Mesothelioma


Conditions: Mesothelioma

Last Updated: March 4, 2020

Status: Recruiting

A Safety and Tolerability Study of INCAGN02390 in Select Advanced Malignancies


Conditions: Carcinoma, Merkel Cell, Carcinoma, Lung Neoplasms, Melanoma, Stomach Neoplasms, Small Cell Lung Carcinoma, Mesothelioma, Triple Negative Breast Neoplasms, Squamous Cell Carcinoma of Head and Neck, Neoplasms

Last Updated: February 14, 2020

Status: Recruiting

Using a Targeted Cancer Vaccine (Galinpepimut-S) With Immunotherapy (Nivolumab) in Mesothelioma


Conditions: Mesothelioma, Wilms Tumor

Last Updated: February 10, 2020

Status: Recruiting

Mesothelioma Stratified Therapy (MiST) : A Multi-drug Phase II Trial in Malignant Mesothelioma


Conditions: Mesothelioma

Last Updated: January 29, 2020

Status: Recruiting

Cabozantinib With Pemetrexed in Advanced Non-small Cell Lung Cancer, Urothelial Cancer and Malignant Mesothelioma


Conditions: Lung Neoplasms, Carcinoma, Non-Small-Cell Lung, Mesothelioma, Carcinoma, Transitional Cell

Last Updated: January 24, 2020

Status: Recruiting

Study of SO-C101 and SO-C101in Combination With Pembro in Adult Patients With Advanced/Metastatic Solid Tumors


Conditions: Carcinoma, Merkel Cell, Carcinoma, Lung Neoplasms, Carcinoma, Non-Small-Cell Lung, Melanoma, Carcinoma, Squamous Cell, Ovarian Neoplasms, Carcinoma, Hepatocellular, Stomach Neoplasms, Uterine Cervical Neoplasms, Urinary Bladder Neoplasms, Carcinoma, Renal Cell, Small Cell Lung Carcinoma, Mesothelioma, Triple Negative Breast Neoplasms, Squamous Cell Carcinoma of Head and Neck, Biliary Tract Neoplasms, Anus Neoplasms, Thymus Neoplasms, Microsatellite Instability

Last Updated: January 15, 2020

Status: Recruiting

Association Between Proton Pump Inhibitors and Hematologic Toxicity of Pemetrexed


Conditions: Mesothelioma

Last Updated: December 13, 2019

Status: Recruiting

TILs & Low-Dose IL-2 Therapy Following Cyclophosphamide and Fludarabine in Pleural Mesothelioma Patients


Conditions: Mesothelioma

Last Updated: December 13, 2019

Status: Recruiting

Autologous CAR-T/TCR-T Cell Immunotherapy for Malignancies


Conditions: Leukemia, Multiple Myeloma, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Mesothelioma, Sarcoma, Synovial, Esophageal Neoplasms, Carcinoma, Renal Cell, Kidney Neoplasms

Last Updated: December 10, 2019

Status: Recruiting

Autologous Dendritic Cell Vaccination in Mesothelioma


Conditions: Mesothelioma

Last Updated: December 6, 2019

Status: Recruiting

Single Arm Study Treating Patients of Peritoneal Surface Malignancy (Colorectal, Appendical, Pseudomyxoma, Gastric) With Cytoreductive Surgery and Hyperthermic Intraperitoneal Mitomycin-C


Conditions: Mesothelioma, Carcinoma, Peritoneal Neoplasms, Pseudomyxoma Peritonei, Appendiceal Neoplasms, Fever

Last Updated: December 4, 2019

Status: Recruiting

Brentuximab Vedotin in Treating Patients With CD30+ Malignant Mesothelioma That Cannot Be Removed by Surgery


Conditions: Mesothelioma, Lung Neoplasms

Last Updated: December 2, 2019

Status: Recruiting

Short Neoadjuvant Hemithoracic IMRT for MPM


Conditions: Mesothelioma

Last Updated: November 25, 2019

Status: Recruiting

Dose Individualization of Pemetrexed - IMPROVE-II


Conditions: Lung Neoplasms, Carcinoma, Non-Small-Cell Lung, Mesothelioma

Last Updated: November 20, 2019

Status: Recruiting

A Feasibility Study Evaluating Surgery for Mesothelioma After Radiation Therapy Using Extensive Pleural Resection


Conditions: Mesothelioma

Last Updated: November 18, 2019

Status: Recruiting

Ph 2/3 Study in Subjects With MPM to Assess ADI-PEG 20 With Pemetrexed and Cisplatin


Conditions: Mesothelioma

Last Updated: November 13, 2019

Status: Recruiting

Mesothelioma and Radical Surgery 2


Conditions: Mesothelioma

Last Updated: October 28, 2019

Status: Recruiting

A Safety and Tolerability Study of INCAGN02385 in Select Advanced Malignancies


Conditions: Carcinoma, Merkel Cell, Carcinoma, Lung Neoplasms, Melanoma, Small Cell Lung Carcinoma, Lymphoma, Large B-Cell, Diffuse, Endometrial Neoplasms, Mesothelioma, Triple Negative Breast Neoplasms, Squamous Cell Carcinoma of Head and Neck, Microsatellite Instability

Last Updated: October 22, 2019

Status: Recruiting

Intraperitoneal MCY-M11 (Mesothelin-targeting CAR) for Treatment of Advanced Ovarian Cancer and Peritoneal Mesothelioma


Conditions: Adenocarcinoma, Mesothelioma, Carcinoma, Ovarian Epithelial

Last Updated: October 21, 2019

Status: Recruiting

Screening of Alberta Asbestos Exposed Workers for Lung Cancer and Mesothelioma


Conditions: Lung Neoplasms, Mesothelioma

Last Updated: October 17, 2019

Status: Recruiting

Neoadjuvant Immune Checkpoint Blockade in Resectable Malignant Pleural Mesothelioma


Conditions: Mesothelioma

Last Updated: October 15, 2019

Status: Recruiting

Naptumomab Estafenatox in Combination With Durvalumab in Subjects With Selected Advanced or Metastatic Solid Tumors


Conditions: Endometrial Neoplasms, Mesothelioma, Carcinoma, Ovarian Epithelial, Kidney Neoplasms, Carcinoma, Hepatocellular

Last Updated: October 10, 2019

Status: Recruiting

Integrated Cancer Repository for Cancer Research


Conditions: Multiple Myeloma, Pancreatic Neoplasms, Esophageal Neoplasms, Endometrial Neoplasms, Thyroid Neoplasms, Mesothelioma, Neuroendocrine Tumors, Salivary Gland Neoplasms, Anus Neoplasms, Gallbladder Neoplasms, Bile Duct Neoplasms, Oropharyngeal Neoplasms, Nasopharyngeal Neoplasms, Nasopharyngeal Carcinoma, Vaginal Neoplasms, Urethral Neoplasms, Laryngeal Neoplasms, Mouth Neoplasms, Adenomatous Polyposis Coli, Testicular Neoplasms, Colorectal Neoplasms, Hereditary Nonpolyposis, Intestinal Neoplasms, Hypopharyngeal Neoplasms, Penile Neoplasms, Ureteral Neoplasms, Peritoneal Neoplasms, Neoplasms, Plasma Cell, Paranasal Sinus Neoplasms, Duodenal Neoplasms, Neoplasms, Unknown Primary, Lip Neoplasms, Thymus Neoplasms, Paraproteinemias, Neoplasms

Last Updated: October 8, 2019

Status: Recruiting

International Registry of Patients Treated With Pressurized IntraPeritoneal Aerosol Chemotherapy (PIPAC)


Conditions: Mesothelioma, Gallbladder Neoplasms, Pancreatic Neoplasms, Pseudomyxoma Peritonei, Appendiceal Neoplasms, Pleural Effusion, Ascites

Last Updated: October 7, 2019

Status: Recruiting

MTG201 Plus Nivolumab in Patients With Relapsed Pleural Mesothelioma


Conditions: Mesothelioma

Last Updated: October 4, 2019

Status: Recruiting

Chemotherapy Followed by Surgery and Neoadjuvant Hemothoracic Intensity Modified Radiation Therapy (IMRT) for Patients With Malignant Pleural Mesothelioma


Conditions: Mesothelioma, Neoplasms, Fibrous Tissue, Solitary Fibrous Tumors, Solitary Fibrous Tumor, Pleural, Pleural Neoplasms

Last Updated: October 2, 2019

Status: Recruiting

Staging Procedures to Diagnose Malignant Pleural Mesothelioma


Conditions: Mesothelioma, Neoplasms, Fibrous Tissue, Solitary Fibrous Tumors, Solitary Fibrous Tumor, Pleural, Pleural Neoplasms

Last Updated: October 2, 2019

Status: Recruiting

Surgery for Mesothelioma After Radiation Therapy "SMART" for Resectable Malignant Pleural Mesothelioma


Conditions: Mesothelioma, Neoplasms, Fibrous Tissue, Solitary Fibrous Tumors, Solitary Fibrous Tumor, Pleural, Pleural Neoplasms

Last Updated: October 2, 2019

Status: Recruiting

Intrapleural Cryotherapy for Malignant Pleural Mesothelioma


Conditions: Mesothelioma

Last Updated: October 1, 2019

Status: Recruiting

Pevonedistat Alone and in Combination With Chemotherapy in Patients With Mesothelioma


Conditions: Mesothelioma

Last Updated: September 25, 2019

Status: Recruiting

Nintedanib as Switch Maintenance Treatment of Pleural Malignant Mesothelioma


Conditions: Mesothelioma

Last Updated: September 18, 2019

Status: Recruiting

Phase I Trial HIPEC With Nal-irinotecan


Conditions: Adenocarcinoma, Mesothelioma, Adenocarcinoma, Mucinous, Cystadenocarcinoma, Pseudomyxoma Peritonei

Last Updated: September 17, 2019

Status: Recruiting

Phase II Nivolumab and Ramucirumab for Patients With Previously-Treated Mesothelioma


Conditions: Mesothelioma

Last Updated: August 15, 2019

Status: Recruiting

APG-2449 in Patients With Advanced Solid Tumors


Conditions: Mesothelioma

Last Updated: June 20, 2019

Status: Recruiting

Rehabilitation by Effort for Patients With Advanced Bronchial Cancer


Conditions: Mesothelioma, Carcinoma, Bronchogenic

Last Updated: April 16, 2019

Status: Recruiting

Clinical Trial of Intraperitoneal Hyperthermic Chemotherapy


Conditions: Mesothelioma, Fallopian Tube Neoplasms, Gastrointestinal Neoplasms, Uterine Neoplasms, Fever

Last Updated: April 15, 2019

Status: Recruiting

Combination of Immunotherapy and Hyperthermia in Advanced Malignant Mesothelioma


Conditions: Mesothelioma, Fever

Last Updated: April 15, 2019

Status: Recruiting

Tazemetostat Rollover Study (TRuST): An Open-Label Rollover Study


Conditions: Lymphoma, Sarcoma, Lymphoma, Large B-Cell, Diffuse, Mesothelioma, Sarcoma, Synovial, Rhabdoid Tumor, Kidney Neoplasms

Last Updated: January 8, 2019

Status: Recruiting

Register With Patients in Which Hyperthermic Intra-Peritoneal Chemotherapy (HIPEC) Was Performed


Conditions: Mesothelioma, Carcinoma, Peritoneal Neoplasms, Pseudomyxoma Peritonei, Fever

Last Updated: October 15, 2018

Status: Recruiting

DENdritic Cell Immunotherapy for Mesothelioma


Conditions: Mesothelioma

Last Updated: July 31, 2018

Status: Recruiting

Study of FAK (Defactinib) and PD-1 (Pembrolizumab) Inhibition in Advanced Solid Malignancies (FAK-PD1)


Conditions: Mesothelioma, Carcinoma, Non-Small-Cell Lung, Pancreatic Neoplasms

Last Updated: March 16, 2018

Status: Recruiting

uPAR-PET for Prognostication in Patients With Non-small Cell Lung Cancer, Malignant Pleural Mesothelioma and Large Cell Neuroendocrine Carcinoma of the Lung


Conditions: Carcinoma, Lung Neoplasms, Carcinoma, Non-Small-Cell Lung, Mesothelioma, Carcinoma, Neuroendocrine

Last Updated: November 18, 2016

Status: Recruiting

Peritoneal Surface Malignancies - Characterization, Models and Treatment Strategies


Conditions: Carcinoma, Mesothelioma, Colorectal Neoplasms, Pseudomyxoma Peritonei, Peritoneal Neoplasms, Neoplasms

Last Updated: October 14, 2015

Status: Recruiting

Written by

Linda Molinari Editor in Chief

Linda Molinari has more than 15 years of experience as a writer and advocate for mesothelioma patients and a ban on asbestos.


Full Bio Editorial Guidelines
Reviewed By

Annette Charlevois Patient Support Coordinator

Annette Charlevois is a senior paralegal at the law firm of Early, Lucarelli, Sweeney & Meisenkothen, helping patients find medical and legal resources.


Full Bio
Icon for

Get Help Contacting


    Privacy policy: All information is secure and will never be released

    TRUSTe

    Free

    Mesothelioma Treatment Guide

    Please fill in the form to request our FREE Mesothelioma Treatment Guide.
    It will be sent to you within 24 hours.

    Free Mesothelioma Treatment Guide



      Privacy policy: All information is secure and will never be released

      TRUSTe